Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?
about
Adjuvant endocrine therapy in women with oestrogen-receptor-positive breast cancer: how should the skeletal and vascular side effects be assessed and managed?
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Adjuvant endocrine therapy in ...... fects be assessed and managed?
@en
Adjuvant endocrine therapy in ...... fects be assessed and managed?
@nl
type
label
Adjuvant endocrine therapy in ...... fects be assessed and managed?
@en
Adjuvant endocrine therapy in ...... fects be assessed and managed?
@nl
prefLabel
Adjuvant endocrine therapy in ...... fects be assessed and managed?
@en
Adjuvant endocrine therapy in ...... fects be assessed and managed?
@nl
P2860
P356
P1476
Adjuvant endocrine therapy in ...... fects be assessed and managed?
@en
P2093
Mathis Grossmann
Sabashini K Ramchand
P2860
P304
P356
10.1111/CEN.13172
P50
P577
2016-08-06T00:00:00Z